Will Versartis Inc (NASDAQ:VSAR) Run Out of Steam Soon? Short Interest is Up

June 14, 2018 - By Darrin Black

Investors sentiment decreased to 0.5 in Q1 2018. Its down 0.01, from 0.51 in 2017Q4. It dropped, as 17 investors sold Versartis, Inc. shares while 29 reduced holdings. 9 funds opened positions while 14 raised stakes. 13.21 million shares or 22.48% less from 17.05 million shares in 2017Q4 were reported.
Goldman Sachs reported 224,223 shares or 0% of all its holdings. Northern owns 357,400 shares. Royal Fincl Bank Of Canada accumulated 0% or 7,422 shares. Tower Capital Ltd Limited Liability Company (Trc) owns 20,686 shares or 0% of their US portfolio. Wells Fargo Mn accumulated 35,238 shares or 0% of the stock. State Board Of Administration Of Florida Retirement Systems has invested 0% in Versartis, Inc. (NASDAQ:VSAR). Rhumbline Advisers owns 29,460 shares for 0% of their portfolio. Citigroup reported 4,045 shares stake. Sabby Mngmt Limited Liability owns 702,364 shares or 0.14% of their US portfolio. Amer holds 21,091 shares or 0% of its portfolio. Voya Inv Mgmt Lc invested in 0% or 14,960 shares. Baker Bros Ltd Partnership reported 1.43 million shares stake. Panagora Asset owns 197,249 shares. Deutsche Savings Bank Ag reported 51,575 shares stake. Alliancebernstein L P stated it has 0% in Versartis, Inc. (NASDAQ:VSAR).

Since March 23, 2018, it had 1 insider buy, and 3 selling transactions for $1.89 million activity. 4,345 shares valued at $7,604 were sold by Woody Tracy M on Friday, March 23. On Wednesday, June 6 AKKARAJU SRINIVAS bought $1.91M worth of Versartis, Inc. (NASDAQ:VSAR) or 1.06 million shares. The insider Stout Jay S sold $7,524.

The stock of Versartis Inc (NASDAQ:VSAR) registered an increase of 8.75% in short interest. VSAR’s total short interest was 2.30 million shares in June as published by FINRA. Its up 8.75% from 2.12M shares, reported previously. With 300,500 shares average volume, it will take short sellers 8 days to cover their VSAR’s short positions. The short interest to Versartis Inc’s float is 7.33%.

The stock increased 7.14% or $0.15 during the last trading session, reaching $2.25. About 716,851 shares traded or 17.89% up from the average. Versartis, Inc. (NASDAQ:VSAR) has declined 91.00% since June 14, 2017 and is downtrending. It has underperformed by 103.57% the S&P500.

Versartis, Inc. operates as an endocrine-focused biopharmaceutical firm in the United States. The company has market cap of $81.18 million. The firm is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase III clinical trials for the treatment of growth hormone deficiency. It currently has negative earnings. It develops drug candidates that it has licensed from Amunix Operating, Inc.

Another recent and important Versartis, Inc. (NASDAQ:VSAR) news was published by Streetinsider.com which published an article titled: “Pre-Open Movers 06/04: (VSAR) (VYGR) (GHDX) Higher; (NKTR) (JNCE) (CFX) Lower (more…)” on June 04, 2018.

Versartis, Inc. (NASDAQ:VSAR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: